Related Experiment Video
Updated: Mar 9, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Development of a Pediatric Adverse Events Terminology
Debbie S Gipson1, Eric S Kirkendall2, Brenda Gumbs-Petty3
1Department of Pediatrics and Communicable Disease, University of Michigan, Ann Arbor, Michigan.
Insights
A new pediatric adverse event (AE) terminology was developed to improve data sharing in pediatric research and safety reporting. This resource offers over 1000 terms for diseases and findings, aiding global collaboration.
Area of Science:
- Pediatric Health and Safety
- Biomedical Informatics
- Clinical Research Terminology
Background:
- Established in 2009, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Pediatric Terminology Harmonization Initiative aimed to standardize pediatric research data.
- A coalition formed the Pediatric Terminology Adverse Event Working Group in 2013 to create standardized terminology for international pediatric adverse event (AE) reporting.
Purpose of the Study:
- To develop a comprehensive and standardized terminology for pediatric adverse events (AEs).
- To facilitate the acquisition and sharing of knowledge across pediatric clinical research, practice, and safety reporting.
Main Methods:
- A multinational group of pediatric specialists and biomedical terminology experts collaborated.
- Developed a working definition of AEs and reviewed concepts from 16 pediatric clinical domains.
- Tested the AE terminology in hospital readmissions and neonatal intensive care unit (NICU) settings.
Main Results:
- The resulting AE terminology includes over 1000 pediatric diseases, disorders, and clinical findings.
- Demonstrated proof-of-concept utility in hospital readmissions and NICU settings.
- The terminology is integrated with established biomedical terminologies and available via the National Cancer Institute's Enterprise Vocabulary Services.
Conclusions:
- The developed AE terminology offers a standardized, temporally focused resource for pediatric health and disease.
- Its compatibility with existing terminologies and availability for unrestricted use promote adoption in diverse settings.
- The terminology is designed for ongoing refinement through user feedback and continued use.
Abstract:
In 2009, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) established the Pediatric Terminology Harmonization Initiative to establish a core library of terms to facilitate the acquisition and sharing of knowledge between pediatric clinical research, practice, and safety reporting. A coalition of partners established a Pediatric Terminology Adverse Event Working Group in 2013 to develop a specific terminology relevant to international pediatric adverse event (AE) reporting. Pediatric specialists with backgrounds in clinical care, research, safety reporting, or informatics, supported by biomedical terminology experts from the National Cancer Institute's Enterprise Vocabulary Services participated. The multinational group developed a working definition of AEs and reviewed concepts (terms, synonyms, and definitions) from 16 pediatric clinical domains. The resulting AE terminology contains >1000 pediatric diseases, disorders, or clinical findings. The terms were tested for proof of concept use in 2 different settings: hospital readmissions and the NICU. The advantages of the AE terminology include ease of adoption due to integration with well-established and internationally accepted biomedical terminologies, a uniquely temporal focus on pediatric health and disease from conception through adolescence, and terms that could be used in both well- and underresourced environments. The AE terminology is available for use without restriction through the National Cancer Institute's Enterprise Vocabulary Services and is fully compatible with, and represented in, the Medical Dictionary for Regulatory Activities. The terminology is intended to mature with use, user feedback, and optimization.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Teratogenicity
Pharmaceutical Poisoning: Potential Scenarios
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Pharmacokinetics in Pediatric Patients: Drug Metabolism

